We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$22.2B
AUM Growth
+$2.18B
Cap. Flow
+$152M
Cap. Flow %
0.68%
Top 10 Hldgs %
45.51%
Holding
3,133
New
154
Increased
1,313
Reduced
1,267
Closed
93

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.6M
3
QCOM icon
Qualcomm
QCOM
+$59.1M
4
CME icon
CME Group
CME
+$58M
5
BKNG icon
Booking.com
BKNG
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Financials 10.86%
3 Communication Services 7.23%
4 Consumer Discretionary 7.21%
5 Industrials 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSP icon
2876
Viant Technology
DSP
$282M
$503 ﹤0.01%
38
+22
+138% +$301
HONE
2877
DELISTED
HarborOne Bancorp
HONE
$502 ﹤0.01%
43
+28
+187% +$306
ARTV
2878
Artiva Biotherapeutics
ARTV
$549M
$497 ﹤0.01%
329
+165
+101% +$347
KIDS icon
2879
OrthoPediatrics
KIDS
$608M
$494 ﹤0.01%
23
-110
-83% -$2.38K
BFST icon
2880
Business First Bancshares
BFST
$1.03B
$493 ﹤0.01%
20
LBRDK icon
2881
Liberty Broadband Class C
LBRDK
$5.18B
$492 ﹤0.01%
5
USNA icon
2882
Usana Health Sciences
USNA
$265M
$488 ﹤0.01%
16
-14
-47% -$398
XOMA
2883
DELISTED
Xoma
XOMA
$479 ﹤0.01%
19
+11
+138% +$263
SB icon
2884
Safe Bulkers
SB
$764M
$477 ﹤0.01%
132
-455
-78% -$1.63K
YMAB
2885
DELISTED
Y-mAbs Therapeutics
YMAB
$469 ﹤0.01%
104
-155
-60% -$697
ORN icon
2886
Orion Group Holdings
ORN
$396M
$463 ﹤0.01%
51
-71
-58% -$532
VIR icon
2887
Vir Biotechnology
VIR
$1.5B
$454 ﹤0.01%
90
+17
+23% +$91
ACRS icon
2888
Aclaris Therapeutics
ACRS
$867M
$452 ﹤0.01%
318
ZNTL icon
2889
Zentalis Pharmaceuticals
ZNTL
$297M
$449 ﹤0.01%
387
+60
+18% +$79
GEVO icon
2890
Gevo
GEVO
$382M
$447 ﹤0.01%
339
RNAC icon
2891
Cartesian Therapeutics
RNAC
$265M
$447 ﹤0.01%
43
-1
-2% -$11
GLRE icon
2892
Greenlight Captial
GLRE
$501M
$445 ﹤0.01%
31
CHRS icon
2893
Coherus Oncology
CHRS
$192M
$438 ﹤0.01%
599
-4,086
-87% -$3.53K
GYRE icon
2894
Gyre Therapeutics
GYRE
$749M
$434 ﹤0.01%
59
-2
-3% -$17
PRPL icon
2895
Purple Innovation
PRPL
$39.6M
$430 ﹤0.01%
+24
New +$442
LNAI
2896
Lunai Bioworks
LNAI
$10.7M
$423 ﹤0.01%
18
+15
+500% +$419
CDLX icon
2897
Cardlytics
CDLX
$22.4M
$421 ﹤0.01%
26
-20
-43% -$345
ESCA icon
2898
Escalade
ESCA
$294M
$419 ﹤0.01%
30
-50
-63% -$737
RYAM icon
2899
Rayonier Advanced Materials
RYAM
$593M
$412 ﹤0.01%
107
-309
-74% -$1.3K
PHLT
2900
DELISTED
Performant Healthcare Inc
PHLT
$408 ﹤0.01%
102
-111
-52% -$315

Similar funds

Nisa Investment Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Nisa Investment Advisors held 3,133 positions worth $22.2B, up 11% from $20B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Nisa Investment Advisors's Q2 2025 filing shows 154 new, 1,313 increased, 1,267 reduced and 93 closed positions. Its largest new stake was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M. The largest sale was NVIDIA, an estimated $65.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

  • Nisa Investment Advisors's largest Q2 2025 buy was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $611M increase.
  • Nisa Investment Advisors's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $65.6M.
  • Nisa Investment Advisors fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q2 2025, selling an estimated $24.3M.
  • Nisa Investment Advisors's ten largest holdings make up 46% of its $22.2B portfolio in Q2 2025.
  • Nisa Investment Advisors opened 154 new positions and closed 93 in Q2 2025.
  • Nisa Investment Advisors's portfolio value rose 11% quarter-over-quarter to $22.2B.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.